Skip to content

Flexible engagement models for every phase of the biopharma lifecycle

With more than a decade of leadership in oncology real-world evidence, Flatiron is helping biopharma companies accelerate development timelines and optimize evidence needs.

Sample outputs of our more common engagement models include:

Quick insights

  • Simple analysis set-up (e.g., coding) and results output

  • Tables and figures to summarize results

End-to-end evidence generation

  • Study protocol / statistical analysis plan

  • Comprehensive analysis, results, and clinical interpretation

  • Publications

  • Regulatory, healthcare provider, or payer communications

Fill out this form to talk to one of our experts and learn more about Flatiron's tailored solutions.